zovir 400 mg tabletter
glaxosmithkline pharma a/s - aciclovir - tabletter - 400 mg
zovir 800 mg tabletter
glaxosmithkline pharma a/s - aciclovir - tabletter - 800 mg
zovirax 80 mg/ml oral suspension
nordic prime aps - aciclovir - oral suspension - 80 mg/ml
livtencity
takeda pharmaceuticals international ag ireland branch - maribavir - cytomegalovirusinfektioner - antivirale midler til systemisk anvendelse - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). det bør overvejes at officielle vejledning om hensigtsmæssig brug af antivirale agenter.
mycophenolatmofetil "accord" 500 mg filmovertrukne tabletter
accord healthcare b.v. - mycophenolatmofetil - filmovertrukne tabletter - 500 mg
zalmoxis
molmed spa - allogen t celler genetisk modificeret med en retroviral vektor kodning for en afkortet form af menneskelige lav affinitet nerve vækstfaktor receptor (Δlngfr) og herpes simplex virus thymidine kinase (hsv-tk mut2) - hematopoietic stem cell transplantation; graft vs host disease - antineoplastiske midler - zalmoxis er indiceret som supplerende behandling ved haploidentisk hæmatopoietisk stamcelle-transplantation (hsct) hos voksne patienter med højrisiko hæmatologiske maligniteter.
zelitrex 250 mg filmovertrukne tabletter
glaxosmithkline pharma a/s - valaciclovirhydrochlorid - filmovertrukne tabletter - 250 mg
zelitrex 500 mg filmovertrukne tabletter
glaxosmithkline pharma a/s - valaciclovirhydrochlorid - filmovertrukne tabletter - 500 mg
valacinova 250 mg filmovertrukne tabletter
paranova danmark a/s - valaciclovirhydrochlorid - filmovertrukne tabletter - 250 mg
valcyte 450 mg filmovertrukne tabletter
abacus medicine a/s - valganciclovirhydrochlorid - filmovertrukne tabletter - 450 mg